Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

What You Need to Know Ahead of Verisk Analytics' Earnings Release

Jersey City, New Jersey-based Verisk Analytics, Inc. (VRSK) engages in the provision of data analytics and technology solutions to the insurance industry in the United States and internationally. With a market cap of $42 billion, the company reports through three business segments: Insurance, Energy and Specialized Markets and Financial Services.

VRSK is scheduled to report its Q2 earnings on Thursday, July 30. Ahead of this event, analysts expect the company to report a profit of $1.77 per share, up 1.7% from $1.74 per share in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in each of the past four quarters, which is impressive.

 

For fiscal 2025, analysts expect VRSK to report an EPS of $7.05, up 6.2% year over year from a profit per share of $6.64 in fiscal 2024. Moreover, in FY2026, the company’s EPS is expected to increase 11.1% annually to $7.83. 

www.barchart.com 

VRSK stock has grown 9.2% over the past 52 weeks, underperforming the Industrial Select Sector SPDR Fund’s (XLI21.7% surge and the S&P 500 Index’s ($SPX12.1% uptick during the same time frame.

www.barchart.com 

On May 7, VRSK shares closed up more than 4% following the release of its Q1 results. The company’s revenue came in at $753 million, beating Wall Street forecasts of $750 million. Moreover, its adjusted EPS of $1.73 exceeded Wall Street expectations by 3.6%. Looking ahead, VRSK expects full-year adjusted EPS in the range of $6.80 to $7.10, and expects revenue in the range of $3 billion to $3.1 billion.

Wall Street analysts are fairly bullish about VRSK’s stock, with a "Moderate Buy" rating overall. Among 19 analysts covering the stock, six recommend "Strong Buy," two suggest a “Moderate Buy,” 10 suggest a “Hold,” and one suggests a “Moderate Sell.” VRSK’s average analyst price target of $316.65 indicates a potential upside of 5.4% from the current levels.

On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.